An ad for a product named "FASENRA" came on TV today. As the ad begins, there is a brief view of a '73 or later 750 Triumph , with it's tank painted 1970 "Spring Gold".

About FASENRA FASENRA was developed by AstraZeneca and is in-licensed from BioWa, Inc., a wholly owned subsidiary of Kyowa Kirin Co., Ltd., Japan.

Fasenra and Nucala are both brand-name drugs. There are currently no biosimilar forms of either drug available. A biosimilar is a drug that's similar to a brand-name medication. A generic drug, on the other hand, is an exact copy of a brand-name medication.

Fasenra is an asthma medicine used to treat adults with a particular type of asthma called eosinophilic asthma. It is used as an additional treatment in adults with severe asthma that is not adequately controlled by a combination of high-dose inhaled corticosteroids plus medicines called long-acting beta-agonists.

FASENRA is indicated for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype. FASENRA is not indicated for treatment of other eosinophilic conditions or for the relief of acute bronchospasm or status asthmaticus.

Fasenra injection is a prescription medicine used together with other asthma medicines to help control severe asthma in adults and children who are at least 12 years old. Fasenra is for people whose asthma is not well controlled with other medications.

Fasenra contains the active drug benralizumab, which is a biologic medication. Biologics are made from living cells rather than from chemicals. Fasenra is also called a monoclonal antibody. This type of drug is a large protein that affects the way certain parts of your body work.

FASENRA is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in people 12 years and older whose asthma is not controlled with their current asthma medicines.

Fasenra belongs to a class of drugs called interleukin-5 monoclonal antibodies.

FASENRA is administered once every 4 weeks for the first three doses, and then once every 8 weeks.

Such as facin ara reduce blood eosinophils USANA fills are a type of white blood cell that may contribute to your asthma. The Sentra is not used to treat other problems caused by youths in a fills.